Ipca Lab Shares

• 

  Ipca Labs Falls 15% As US Regulator Bans Drug Import

  According to Ipca Laboratories, the FDA has refused admission to all drugs made at the company's Pithampur and Silvassa facility.

• 

  US Regulator Warns IPCA Labs on Manufacturing Lapses at 3 Plants

  Drug maker IPCA Laboratories Ltd said the US Food and Drug Administration (FDA) issued it a warning letter outlining manufacturing quality lapses observed at three of its Indian factories, pushing its shares down as much as 16 per cent.

• 

  IPCA Labs Shares Crash on Warning Letter from USFDA

  IPCA Laboratories shares crashed 16.27 per cent on Monday after the drugmaker said it has received a warning letter from US drug regulator highlighting manufacturing quality lapses at three of its units.

• 

  IPCA Lab Gains as RBI Removes FII Restrictions

  The Reserve Bank withdrew restrictions placed on foreign investors to purchase shares of Ipca Laboratories as foreign institutional investors' shareholding in Ipca Lab had gone below the revised threshold caution limit.

• Tata Motors, Ipca Labs, GMR Infra in Focus Today

  The Nifty opened higher on Wednesday. Foreign investors continued their buying spree and on Tuesday they have bought shares worth Rs 738 crore. However, domestic investors were net sellers to the tunes of Rs 632 crore. Trading volume increased on Tuesday; cash segment registered a volume of Rs 18,845 crore (up13.5% than Monday's volume), derivativ...

• IPCA Labs Comes Under USFDA Scanner, Stock Plunges Over 15%

  Earlier IPCA had discontinued manufacturing voluntarily at its Ratlam facility after USFDA had found serious issues at its Ratlam API facility.

• Ipca gains on 'outperform' rating by Credit Suisse

  Shares in Ipca Laboratories rose today after Credit Suisse initiated coverage on the stock with an "outperform" rating, traders say.

• Ipca Labs Q3 net profit down marginally at Rs 63.93 cr

  Drug firm Ipca Laboratories said its net profit dipped marginally by 0.03 per cent to Rs 63.93 crore